Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 11, 2018

SELL
$146.33 - $183.18 $6,438 - $8,059
-44 Closed
0 $0
Q1 2018

Apr 09, 2018

SELL
$135.59 - $157.16 $3.47 Million - $4.03 Million
-25,614 Reduced 99.83%
44 $7,000
Q4 2017

Jan 18, 2018

SELL
$131.06 - $150.39 $412,707 - $473,578
-3,149 Reduced 10.93%
25,658 $3.46 Million
Q3 2017

Oct 12, 2017

BUY
$142.62 - $155.6 $4.11 Million - $4.48 Million
28,807
28,807 $4.21 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $8.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Contravisory Investment Management, Inc. Portfolio

Follow Contravisory Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Contravisory Investment Management, Inc. with notifications on news.